|
Article ID: 707928 Man with Rare Heart Tumor has Robotic Cardiac SurgeryWestern Connecticut Health NetworkTony Teixeira from Danbury, Connecticut had minimally invasive robotic surgery to remove a rare heart tumor. Released:12-Feb-2019 8:15 AM ESTChannels: Cardiovascular Health, Heart Disease, Surgery, Local - Connecticut Danbury Hospital, WCMG Southbury Cardiology, Dr. Harvey Kramer, Dr. Robert Gallagher, Robotic Cardiac Surgery, Dr. John Pezzimenti, Hodgkin’s Lymphoma, Radiation Therapy, Fairfield County Bank, Cardiovascular, Primary Cardiac Tumor, Heart Tumor, Myxomas, Papillary Fibroelastoma |
 Article ID: 707521 Danbury Hospital: Minimally Invasive Procedure Heals Woman’s HeartWestern Connecticut Health NetworkAn 86-year old woman from Danbury, Connecticut had Transcatheter Aortic Valve Replacement (TAVR) to treat severe aortic stenosis. TAVR is a minimally invasive procedure that is a safe alternative for patients who are at intermediate to high risk of complications from open heart surgery. Released:5-Feb-2019 9:15 AM EST |
|
Article ID: 707305 Woman Gets New Hip, Home Same DayWestern Connecticut Health NetworkNorwalk Hospital same day total joint replacement surgery leaves patient highly active and pain-free Released:31-Jan-2019 8:45 AM EST |
|
Article ID: 706423 Research reveals strategies for combating science misinformationYale School OF Forestry & Environmental StudiesJust as the scientific community was reaching a consensus on the dangerous reality of climate change, the partisan divide on climate change began to widen. Released:14-Jan-2019 12:40 PM EST |
Article ID: 705690 Yale Cancer Center scientists advise caution in immunotherapy researchYale Cancer CenterIn a new study by Yale Cancer Center (YCC), scientists suggest that as the number of clinical trials in cancer immunotherapy grows exponentially, some caution should be exercised as we continue to better understand the biology of these new therapeutic targets. Released:19-Dec-2018 12:05 PM EST |
Article ID: 703627 Yale Cancer Center scientists show immunotherapy drug can help patients with metastatic melanomaYale Cancer CenterWhen melanoma turns metastatic, it spreads to the brain in more than 40% of patients. Published today in the Journal of Clinical Oncology (JCO), a study by Yale Cancer Center researchers show a checkpoint inhibitor immunotherapy drug has meaningful benefit for these patients. Released:8-Nov-2018 11:05 AM EST |
 Article ID: 703518 Yale Cancer Center Finds Patients Choose Cancer Care Based on Hospital AffiliationsYale Cancer CenterBranding matters when it comes to choosing a hospital, according to a new novel study by Yale Cancer Center (YCC) researchers published in the journal Annals of Surgical Oncology. Released:7-Nov-2018 9:30 AM EST |
 Article ID: 703425 Yale Cancer Center investigators show recommended, but underused treatment for rare blood cancer saves livesYale Cancer CenterU.S. and European guidelines on treating Polycythemia Vera (PV), a potentially deadly blood cancer, call for two treatments for patients with high-risk disease: therapeutic phlebotomy and cytoreductive therapy with a drug called hydroxyurea (HU). HU is the most commonly used option, but evidence for HU treatment is limited and both treatments are underused. Now, researchers at Yale Cancer Center have documented reduced risk of death and incidence of blood clots in patients receiving those therapies. Released:5-Nov-2018 5:05 PM EST |
 Article ID: 703369 Antonio Omuro named new Neuro-Oncology Chief at Yale Cancer CenterYale Cancer CenterAntonio Omuro, M.D., has been appointed the new Chief of Neuro-Oncology and a Leader for the Brain Tumor Program at Yale Cancer Center (YCC) and Smilow Cancer Hospital. Released:5-Nov-2018 10:45 AM ESTChannels: Cancer, Neuro, Local - Connecticut Yale Cancer Center, Cancer, Brian Cancer, Neuro-oncology, Brain, Antonio Omuro, YALE |
Article ID: 699077 Discovery May Help Provide Clues for Fighting and Treating HPVYale Cancer CenterYale Cancer Center (YCC) scientists have filled in a key gap in understanding the unusual route by which the Human papillomavirus (HPV) infects cells. Released:15-Aug-2018 7:05 PM EDT |
